154 related articles for article (PubMed ID: 23480555)
1. Exploring the biology of cancer of unknown primary: breakthroughs and drawbacks.
Kamposioras K; Pentheroudakis G; Pavlidis N
Eur J Clin Invest; 2013 May; 43(5):491-500. PubMed ID: 23480555
[TBL] [Abstract][Full Text] [Related]
2. Cancer of unknown primary site: missing primary or missing biology?
Pentheroudakis G; Briasoulis E; Pavlidis N
Oncologist; 2007 Apr; 12(4):418-25. PubMed ID: 17470684
[TBL] [Abstract][Full Text] [Related]
3. Identifying the primary site using gene expression profiling in patients with carcinoma of an unknown primary (CUP): a feasibility study from the GEFCAPI.
Gross-Goupil M; Massard C; Lesimple T; Merrouche Y; Blot E; Loriot Y; Mathieu MC; Fizazi K
Onkologie; 2012; 35(1-2):54-5. PubMed ID: 22310348
[No Abstract] [Full Text] [Related]
4. [CUP syndrome: are there advances?].
Moll R
Verh Dtsch Ges Pathol; 2005; 89():125-36. PubMed ID: 18035682
[TBL] [Abstract][Full Text] [Related]
5. Perspectives for targeted therapies in cancer of unknown primary site.
Pentheroudakis G; Pavlidis N
Cancer Treat Rev; 2006 Dec; 32(8):637-44. PubMed ID: 17046164
[TBL] [Abstract][Full Text] [Related]
6. Switching benchmarks in cancer of unknown primary: from autopsy to microarray.
Pentheroudakis G; Golfinopoulos V; Pavlidis N
Eur J Cancer; 2007 Sep; 43(14):2026-36. PubMed ID: 17698346
[TBL] [Abstract][Full Text] [Related]
7. Identification of tissue of origin in carcinoma of unknown primary with a microarray-based gene expression test.
Monzon FA; Medeiros F; Lyons-Weiler M; Henner WD
Diagn Pathol; 2010 Jan; 5():3. PubMed ID: 20205775
[TBL] [Abstract][Full Text] [Related]
8. Molecular profiling diagnosis in unknown primary cancer: accuracy and ability to complement standard pathology.
Greco FA; Lennington WJ; Spigel DR; Hainsworth JD
J Natl Cancer Inst; 2013 Jun; 105(11):782-90. PubMed ID: 23641043
[TBL] [Abstract][Full Text] [Related]
9. Prospective gene signature study using microRNA to identify the tissue of origin in patients with carcinoma of unknown primary.
Varadhachary GR; Spector Y; Abbruzzese JL; Rosenwald S; Wang H; Aharonov R; Carlson HR; Cohen D; Karanth S; Macinskas J; Lenzi R; Chajut A; Edmonston TB; Raber MN
Clin Cancer Res; 2011 Jun; 17(12):4063-70. PubMed ID: 21531815
[TBL] [Abstract][Full Text] [Related]
10. Cancer of Unknown Primary origin in the genomic era: Elucidating the dark box of cancer.
Economopoulou P; Mountzios G; Pavlidis N; Pentheroudakis G
Cancer Treat Rev; 2015 Jul; 41(7):598-604. PubMed ID: 26033502
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a gene expression tumour classifier for cancer of unknown primary.
Tothill RW; Shi F; Paiman L; Bedo J; Kowalczyk A; Mileshkin L; Buela E; Klupacs R; Bowtell D; Byron K
Pathology; 2015 Jan; 47(1):7-12. PubMed ID: 25485653
[TBL] [Abstract][Full Text] [Related]
12. Redefining cancer of unknown primary: Is precision medicine really shifting the paradigm?
Olivier T; Fernandez E; Labidi-Galy I; Dietrich PY; Rodriguez-Bravo V; Baciarello G; Fizazi K; Patrikidou A
Cancer Treat Rev; 2021 Jun; 97():102204. PubMed ID: 33866225
[TBL] [Abstract][Full Text] [Related]
13. Low serum albumin levels and liver metastasis are powerful prognostic markers for survival in patients with carcinomas of unknown primary site.
Seve P; Ray-Coquard I; Trillet-Lenoir V; Sawyer M; Hanson J; Broussolle C; Negrier S; Dumontet C; Mackey JR
Cancer; 2006 Dec; 107(11):2698-705. PubMed ID: 17063500
[TBL] [Abstract][Full Text] [Related]
14. The unknown biology of the unknown primary tumour: a literature review.
van de Wouw AJ; Jansen RL; Speel EJ; Hillen HF
Ann Oncol; 2003 Feb; 14(2):191-6. PubMed ID: 12562643
[TBL] [Abstract][Full Text] [Related]
15. [Cancer of unknown primary site origin--advances in diagnosis and therapy].
Plot L; Dovrish Z; Hadari R; Weisenberg N; Zehavi T; Nisenbaum B; Amital H
Harefuah; 2008 Apr; 147(4):294-8, 376, 375. PubMed ID: 18686808
[TBL] [Abstract][Full Text] [Related]
16. Carcinoma of unknown primary (CUP); some considerations about pathogenesis and diagnostic strategy, particularly focusing on CUPS pertaining to the Urology.
Alberti C
G Chir; 2012; 33(1-2):41-6. PubMed ID: 22357439
[TBL] [Abstract][Full Text] [Related]
17. [The initial CUP situation and CUP syndrome: pathological diagnostics].
Moll R
Pathologe; 2009 Dec; 30 Suppl 2():161-7. PubMed ID: 19816686
[TBL] [Abstract][Full Text] [Related]
18. Predicting the site of origin of tumors by a gene expression signature derived from normal tissues.
Staub E; Buhr HJ; Gröne J
Oncogene; 2010 Aug; 29(31):4485-92. PubMed ID: 20514016
[TBL] [Abstract][Full Text] [Related]
19. Carcinoma of unknown primary (CUP).
Pavlidis N; Fizazi K
Crit Rev Oncol Hematol; 2009 Mar; 69(3):271-8. PubMed ID: 18977667
[TBL] [Abstract][Full Text] [Related]
20. Cancers of unknown primary origin (CUP) are characterized by chromosomal instability (CIN) compared to metastasis of know origin.
Vikeså J; Møller AK; Kaczkowski B; Borup R; Winther O; Henao R; Krogh A; Perell K; Jensen F; Daugaard G; Nielsen FC
BMC Cancer; 2015 Mar; 15():151. PubMed ID: 25885340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]